MMSI250117P80000
- 0.95
- 0.000.00%
Merit Medical Systems Newsroom
Merit Financial Advisors Partners With Zimmermann Investment Management & Planning and Establishes Fourth Office in Pennsylvania
Merit Medical Systems' (NASDAQ:MMSI) Investors Will Be Pleased With Their Strong 182% Return Over the Last Five Years
Here's Why You Should Add MMSI Stock to Your Portfolio Now
BDX Vs. MMSI: Which Stock Is the Better Value Option?
Merit Medical Is Maintained at Outperform by Raymond James
Raymond James Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Raises Target Price to $110
Express News | Merit Medical Systems Inc : Raymond James Raises Target Price to $110 From $105
Merit Medical Stock Rises Following FDA Nod for WRAPSODY Device
Barrington Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $114
Merit Medical Systems: Promising Growth With Wrapsody Device Approval and Market Expansion
Barrington Research Maintains Outperform on Merit Medical Systems, Maintains $114 Price Target
Merit Medical Systems Analyst Ratings
With EPS Growth And More, Merit Medical Systems (NASDAQ:MMSI) Makes An Interesting Case
Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Express News | Merit Medical Systems Inc - to Begin Commercialization of Wrapsody in USA in 2025
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
Express News | Merit Medical Announces FDA Approval of the Wrapsody Cell-Impermeable Endoprosthesis